Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -50.92% is 18% below its 5-year average of -42.99%, around the middle of its 5-year range (-68.13%–-15.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.75% below its 12-month average of -45.57%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -50.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-50.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-45.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-46.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-42.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.75%
CURRENT VS 3Y AVG
-8.93%
CURRENT VS 5Y AVG
-18.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-42.87%
vs the sector median at left
Olema Pharmaceuticals, Inc.
Market Cap
$691.79M
Return on Invested Capital (ROIC)
-50.92%
TTM Avg
-45.57%
3Y Avg
-46.75%
5Y Avg
-42.99%
Market Cap
$693.19M
Return on Invested Capital (ROIC)
-110.62%
TTM Avg
-99.41%
3Y Avg
-74.42%
5Y Avg
-73.36%
Market Cap
$693.61M
Return on Invested Capital (ROIC)
-42.94%
TTM Avg
-42.70%
3Y Avg
-94.89%
5Y Avg
-93.87%
Market Cap
$694.79M
Return on Invested Capital (ROIC)
-12.00%
TTM Avg
-7.53%
3Y Avg
-5.45%
5Y Avg
-2.27%
Market Cap
$685.49M
Return on Invested Capital (ROIC)
-41.63%
TTM Avg
-2189.24%
3Y Avg
-1224.39%
5Y Avg
-874.41%
Market Cap
$681.27M
Return on Invested Capital (ROIC)
-54.12%
TTM Avg
-85.96%
3Y Avg
-71.51%
5Y Avg
-63.27%
Market Cap
$681.02M
Return on Invested Capital (ROIC)
-118.97%
TTM Avg
-130.14%
3Y Avg
-108.49%
5Y Avg
-89.69%
Market Cap
$702.82M
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$709.65M
Return on Invested Capital (ROIC)
6.11%
TTM Avg
9.98%
3Y Avg
8.97%
5Y Avg
8.63%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | $691.79M | -50.92% | -45.57% | -46.75% | -42.99% |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | -110.62% | -99.41% | -74.42% | -73.36% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | -42.94% | -42.70% | -94.89% | -93.87% |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | -12.00% | -7.53% | -5.45% | -2.27% |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | -41.63% | -2189.24% | -1224.39% | -874.41% |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | -54.12% | -85.96% | -71.51% | -63.27% |
| Verastem, Inc. (VSTM)vs › | $681.02M | -118.97% | -130.14% | -108.49% | -89.69% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $702.82M | -47.96% | -47.20% | -41.20% | -37.18% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.65M | 6.11% | 9.98% | 8.97% | 8.63% |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 1.97% | 18.16% | 11.04% | 1.26% |
ROIC
-50.9%
ROE
-47.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -50.92% |
| 2026-03-31 | -41.66% |
| 2025-12-31 | -37.02% |
| 2025-09-30 | -53.21% |
| 2025-06-30 | -45.04% |
| 2025-03-31 | -37.23% |
| 2024-12-31 | -34.66% |
| 2024-09-30 | -68.13% |
| 2024-06-30 | -53.34% |
| 2024-03-31 | -46.19% |
| 2023-12-31 | -41.11% |
| 2023-09-30 | -36.76% |
| 2023-06-30 | -62.44% |
| 2023-03-31 | -64.26% |
| 2022-12-31 | -53.74% |
| 2022-09-30 | -46.26% |
| 2022-06-30 | -40.31% |
| 2022-03-31 | -29.67% |
| 2021-12-31 | -24.92% |
| 2021-09-30 | -19.90% |
| 2021-06-30 | -15.91% |
| 2021-03-31 | -11.02% |
| 2020-12-31 | -6.37% |
| 2020-09-30 | -9.90% |
